Per-Henrik Holmqvist

Per-Henrik has more than 20 years of experience from cell- and molecular biology research in academic and private sector. The last 6.5 years in immune cell therapy with the focus on ATMP production processes under GMP for clinical trials.

Per-Henrik defended his PhD thesis in epigenetics at the institute of Cell- and Molecular Biology, Karolinska Institute in 2005.